Best Pharma ETFs To Invest For Long Term In India 2021

The IT and pharma pack are two sectors which are seen to be multibaggers in few years time. So, if you are too keen to make good returns from the space but are not able to shortlist on few of the good pharma scrips, you can bet on Pharma ETFs. In fact Divis labs is one such stock that has been given a thumbs up by analyst to be the next multibagger.

Prospects of Pharma sector

While even before the outbreak of the pandemic, stock market experts have been bullish on the sector, the pandemic has only upped the prospect for the sector. The Niti Aayog report has suggested that the pharma space has emerged as the largest in terms of both revenue as well as employment.

Now given the government push i.e. both for the vaccination as well as the funding for the healthcare sector, it is estimated to reach $372 billion by the year 2022.

Other positives for the sector include Aatmanirbhar push as a result the centre has already earmarked Rs. 6940 crore investment towards the ssector under the PLI scheme for promoting domestic manufacturing of bulk drugs across 53 APIs (active pharmaceutical ingredients) over the next six years.

{photo-feature}